{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T07:59:55Z","timestamp":1701331195254},"reference-count":49,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,7,15]]},"DOI":"10.2169\/internalmedicine.4298-19","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T22:08:14Z","timestamp":1586988494000},"page":"1695-1704","source":"Crossref","is-referenced-by-count":2,"title":["The Molar Ratio of Total Branched-chain Amino Acids to Tyrosine Predicts a Digit Symbol Test Abnormality in Cirrhotic Patients"],"prefix":"10.2169","volume":"59","author":[{"given":"Yusuke","family":"Mizuno","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, The Jikei University Daisan Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinya","family":"Ishida","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akemi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Clinical Nutritional Supports, Jikei University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Konakahara","sequence":"additional","affiliation":[{"name":"Clinical Nutritional Supports, Jikei University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, The Jikei University Daisan Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Hama","sequence":"additional","affiliation":[{"name":"Clinical Nutritional Supports, Jikei University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Hokari","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, The Jikei University Katsushika Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Saruta","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Stewart CA, Malinchoc M, Kim WR, Kamath PS. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 13: 1366-1371, 2007.","DOI":"10.1002\/lt.21129"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bustamante J, Rimola A, Ventura PJ, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 30: 890-895, 1999.","DOI":"10.1016\/S0168-8278(99)80144-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Garg H, Kumar A, Garg V, Sharma P, Sharma BC, Sarin SK. Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure. Dig Liver Dis 44: 166-171, 2012.","DOI":"10.1016\/j.dld.2011.08.029"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 96: 2718-2723, 2001.","DOI":"10.1016\/S0002-9270(01)02692-2"},{"key":"5","unstructured":"5. Kato A, Tanaka H, Kawaguchi T, et al. Nutritional management contributes to improvement in minimal hepatic encephalopathy and quality of life in patients with liver cirrhosis: a preliminary, prospective, open-label study. Hepatol Res 43: 452-458, 2013."},{"key":"6","unstructured":"6. Bajaj JS, Pinkerton SD, Sanyal AJ, Heuman DM. Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis. Hepatology 55: 1164-1171, 2012."},{"key":"7","unstructured":"7. Dhiman RK, Saraswat VA, Sharma BK, et al. Minimal hepatic encephalopathy: Consensus statement of a working party of the indian national association for study of the liver. J Gastroenterol Hepatol 25: 1029-1041, 2010."},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th world congresses of gastroenterology, vienna, 1998. Hepatology 35: 716-721, 2002.","DOI":"10.1053\/jhep.2002.31250"},{"key":"9","unstructured":"9. Randolph C, Hilsabeck R, Kato A, et al. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 29: 629-635, 2009."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kato A, Kato M, Ishii H, et al. Development of quantitative neuropsychological tests for diagnosis of subclinical hepatic encephalopathy in liver cirrhosis patients and establishment of diagnostic criteria-multicenter collaborative study in japanese. Hepatol Res 30: 71-78, 2004.","DOI":"10.1016\/j.hepres.2004.07.001"},{"key":"11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/hep.21533","volume":"45","author":"S Prasad","year":"2007","unstructured":"11. Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 45: 549-559, 2007.","journal-title":"Hepatology","ISSN":"http:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Michitaka K, Tokumoto Y, Uesugi K, et al. Neuropsychiatric dysfunction in patients with chronic hepatitis and liver cirrhosis. Hepatol Res 38: 1069-1075, 2008.","DOI":"10.1111\/j.1872-034X.2008.00374.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Bajaj JS, Saeian K, Verber MD, et al. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 102: 754-760, 2007.","DOI":"10.1111\/j.1572-0241.2007.01048.x"},{"key":"14","unstructured":"14. Maric D, Klasnja B, Filipovic D, Brkic S, Ruzic M, Bugarski V. Minimal hepatic encephalopathy in patients with decompensated liver cirrhosis. Acta Clin Croat 50: 375-380, 2011."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Li SW, Wang K, Yu YQ, Wang HB, Li YH, Xu JM. Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China. World J Gastroenterol 19: 8745-8751, 2013.","DOI":"10.3748\/wjg.v19.i46.8745"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34: 768-773, 2001.","DOI":"10.1016\/S0168-8278(01)00026-5"},{"key":"17","unstructured":"17. Nishikawa H, Shiraki M, Hiramatsu A, Moriya K, Hino K, Nishiguchi S. Japan society of hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res 46: 951-963, 2016."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kawaguchi T, Konishi M, Kato A, et al. Updating the neuropsychological test system in japan for the elderly and in a modern touch screen tablet society by resetting the cut-off values. Hepatol Res 47: 1335-1339, 2017.","DOI":"10.1111\/hepr.12864"},{"key":"19","unstructured":"19. Long CL, Schaffel N, Geiger JW, Schiller WR, Blakemore WS. Metabolic response to injury and illness: Estimation of energy and protein needs from indirect calorimetry and nitrogen balance. JPEN J Parenter Enteral Nutr 3: 452-456, 1979."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Barak N, Wall-Alonso E, Sitrin MD. Evaluation of stress factors and body weight adjustments currently used to estimate energy expenditure in hospitalized patients. JPEN J Parenter Enteral Nutr 26: 231-238, 2002.","DOI":"10.1177\/0148607102026004231"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tsuboyama-Kasaoka N, Takizawa A, Tsubota-Utsugi M, et al. Dietary intake of nutrients with adequate intake values in the dietary reference intakes for japanese. J Nutr Sci Vitaminol (Tokyo) 59: 584-595, 2013.","DOI":"10.3177\/jnsv.59.584"},{"key":"22","unstructured":"22. Tsubota-Utsugi M, Imai E, Nakade M, Tsuboyama-Kasaoka N, Morita A, Tokudome S. Dietary reference intakes for japanese -2010-."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 48: 452-458, 2013.","DOI":"10.1038\/bmt.2012.244"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Tajika M, Kato M, Mohri H, et al. Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition 18: 229-234, 2002.","DOI":"10.1016\/S0899-9007(01)00754-7"},{"key":"25","unstructured":"25. Tsiaousi ET, Hatzitolios AI, Trygonis SK, Savopoulos CG. Malnutrition in end stage liver disease: recommendations and nutritional support. J Gastroenterol Hepatol 23: 527-533, 2008."},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Albrecht J, Norenberg MD. Glutamine: a trojan horse in ammonia neurotoxicity. Hepatology 44: 788-794, 2006.","DOI":"10.1002\/hep.21357"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Plauth M, Merli M, Kondrup J, et al. ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr 16: 43-55, 1997.","DOI":"10.1016\/S0261-5614(97)80022-2"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Muller MJ, Bottcher J, Selberg O, et al. Hypermetabolism in clinically stable patients with liver cirrhosis. Am J Clin Nutr 69: 1194-1201, 1999.","DOI":"10.1093\/ajcn\/69.6.1194"},{"key":"29","unstructured":"29. Plauth M, Cabre E, Riggio O, et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr 25: 285-294, 2006."},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Amodio P, Bemeur C, Butterworth R, et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International society for hepatic encephalopathy and nitrogen metabolism consensus. Hepatology 58: 325-336, 2013.","DOI":"10.1002\/hep.26370"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Hirano H, Saito M, Yano Y, et al. Chronic liver disease questionnaire would be a primary screening tool of neuropsychiatric test detecting minimal hepatic encephalopathy of cirrhotic patients. Hepatol Res 45: 994-1003, 2015.","DOI":"10.1111\/hepr.12442"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Hanai T, Shiraki M, Watanabe S, et al. Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis. Hepatol Res 47: 1359-1367, 2017.","DOI":"10.1111\/hepr.12873"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kinny-Koster B, Bartels M, Becker S, et al. Plasma amino acid concentrations predict mortality in patients with end-stage liver disease. PLoS One 11: e0159205, 2016.","DOI":"10.1371\/journal.pone.0159205"},{"key":"34","unstructured":"34. Holecek M. Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy. Nutrition 31: 14-20, 2015."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Kato A, Suzuki K. How to select BCAA preparations. Hepatol Res 30S: 30-35, 2004.","DOI":"10.1016\/j.hepres.2004.08.008"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Manoli I, Venditti CP. Disorders of branched chain amino acid metabolism. Transl Sci Rare Dis 1: 91-110, 2016.","DOI":"10.3233\/TRD-160009"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Akahoshi M, Ichikawa T, Taura N, et al. Sleep disturbances and quality of life in patients after living donor liver transplantation. Transplant Proc 46: 3515-3522, 2014.","DOI":"10.1016\/j.transproceed.2014.08.041"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Bredin C, Naimimohasses S, Norris S, et al. Development and relative validation of a short food frequency questionnaire for assessing dietary intakes of non-alcoholic fatty liver disease patients. Eur J Nutr 59: 571-580, 2020.","DOI":"10.1007\/s00394-019-01926-5"},{"key":"39","unstructured":"39. Cade JE, Burley VJ, Warm DL, Thompson RL, Margetts BM. Food frequency questionnaires: a review of their design, validation and utilisation. Nutr Res Rev 17: 5-22, 2004."},{"key":"40","unstructured":"40. Denissen KFM, Boonen A, Nielen JTH, et al. Consumption of dairy products in relation to the presence of clinical knee osteoarthritis: the maastricht study. Eur J Nutr 58: 2693-2704, 2019."},{"key":"41","unstructured":"41. Eng JY, Moy FM. Validation of a food frequency questionnaire to assess dietary cholesterol, total fat and different types of fat intakes among malay adults. Asia Pac J Clin Nutr 20: 639-645, 2011."},{"key":"42","doi-asserted-by":"publisher","unstructured":"42. Kanehara R, Goto A, Kotemori A, et al. Validity and reproducibility of a self-administered food frequency questionnaire for the assessment of sugar intake in middle-aged Japanese adults. Nutrients 11: 554, 2019.","DOI":"10.3390\/nu11030554"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Marshall SJ, Livingstone KM, Celis-Morales C, et al. Reproducibility of the online Food4Me food-frequency questionnaire for estimating dietary intakes across europe. J Nutr 146: 1068-1075, 2016.","DOI":"10.3945\/jn.115.225078"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Shim JS, Oh K, Kim HC. Dietary assessment methods in epidemiologic studies. Epidemiol Health 36: 1-8, 2014.","DOI":"10.4178\/epih\/e2014009"},{"key":"45","doi-asserted-by":"publisher","unstructured":"45. Perumpail BJ, Li AA, Cholankeril G, Kumari R, Ahmed A. Optimizing the nutritional support of adult patients in the setting of cirrhosis. Nutrients 9: 1114, 2017.","DOI":"10.3390\/nu9101114"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Shawcross DL. Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy? Expert Rev Gastroenterol Hepatol 9: 539-542, 2015.","DOI":"10.1586\/17474124.2015.1035257"},{"key":"47","unstructured":"47. Malaguarnera G, Giordano M, Nunnari G, Bertino G, Malaguarnera M. Gut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectives. World J Gastroenterol 20: 16639-16648, 2014."},{"key":"48","doi-asserted-by":"publisher","unstructured":"48. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 39: 1441-1449, 2004.","DOI":"10.1002\/hep.20194"},{"key":"49","unstructured":"49. Zhu S, Zhao J, Chen Z, Wang Y. Influential factors on cognitive performance in middle-aged cohort: Third national health and nutrition examination survey-based study. Medicine (Baltimore) 97: e12033, 2018."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/14\/59_4298-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T03:31:31Z","timestamp":1595043091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/14\/59_4298-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,15]]},"references-count":49,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4298-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,15]]}}}